Tradestie Institutional Equity Comparison Engine

RKTO vs ENSC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (3โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RKTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, RKTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
RKTO N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner ENSC
Op Margin N/A vs -281.3% ยท YoY N/A vs -15.1%
Momentum & Technical Winner ENSC
1Y -82.5% vs -80.3% ยท 52W Pos 2% vs 8%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RKTO US Equity
RKTO
Institutional Equity
$0.30
+6.11% 1D
Market Cap N/A
1M Return -44.23%
1Y Return -82.53%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 45.0 Fund 42.0 Flow 50.0 Mom 55.0
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RKTO -82.53% ENSC -80.33% Spread: +102.13 pp (ENSC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RKTO TTM Op. Margin: N/A ENSC TTM Op. Margin: -281.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RKTO vs ENSC. Trailing 12-month operating profitability (RKTO N/A vs ENSC -281.3%) and valuation multiples (RKTO N/M vs ENSC 0.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RKTO (1) vs ENSC (9)
Institutional Metric RKTO ENSC Criterion Row Winner
Market Capitalization Scale N/A $7.0M Larger Scale ENSC
Trailing P/E Ratio Valuation N/M 0.8x Lower Multiple ENSC
Forward P/E Ratio Valuation N/M 0.8x Lower Multiple ENSC
Revenue Growth (YoY) Growth N/A -15.1% Higher Growth ENSC
Operating Margin (TTM) Profitability N/A -281.3% Higher Margin ENSC
Net Profit Margin Profitability N/A -280.5% Higher Margin ENSC
Return on Equity (ROE) Capital Efficiency N/A -1295.1% Higher ROE ENSC
52-Week Range Position Momentum 2% ($0โ€“$2) 8% ($0โ€“$2) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 1.16ฮฒ ยท 63% Vol 0.98ฮฒ ยท 79% Vol Lower Realized Risk RKTO
Unified Institutional Score Composite Signal 44.2 / 100 (HOLD) 53.4 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RKTO vs ENSC Buy Guide
RKTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RKTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RKTO nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.